In the past three weeks, hospital pharmacist Jesse Swen and PhD candidate Cathelijne van der Wouden (coordinating team at LUMC) have visited all PREPARE study sites to meet the local research teams. Continue reading
The 1st UPGx Personalized Medicine Day, the first of a series of dissemination events for healthcare professionals and biomedical scientists that will be organized by the UPGx project, has been successfully held on Thursday December 1st, 2016 in Granada, Spain. Continue reading
The 2016 Golden Helix Summer School with the theme “Cancer Genomics and Individualized Therapy” was successfully organized at the Dolphin Bay Resort hotel in Syros island, Greece, 22-26 September 2016. Continue reading
This is an anonymous questionnaire to evaluate the views and knowledge of current drug prescribers on pharmacogenomics and its role in individualizing patient treatment.
The results of this questionnaire will support the development of a short e-Learning Tool on pharmacogenomics for clinicians and pharmacists.
To be updated
To be updated
David Haerry is a patients’ advocate. He is a member of the European AIDS Treatment Group (EATG). David has been involved in HIV drug development for many years and has specific interests in the areas of Personalised Medicine, Risk Communication and Doctor/Patient Communication, Pharmacovigilance, Observational Studies, Biomedical Prevention and HIV Eradication Research.
The 17th Golden Helix Pharmacogenomics Day was successfully organized in Rotterdam, the Netherlands May 27th, 2016 by the Golden Helix Foundation and the Erasmus University Medical Center. Overall, the conference was attended by 164 participants from over 10 countries from Europe and the United States and was under the auspices of several national and international organizations, such as the Dutch Royal Pharmacists Association, the Genomic Medicine Alliance, the International Federation of Clinical Chemistry, and others.